Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum Levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF

Journal of Surgical Oncology

Volumn 89, Issue 4, 2005, Pages 273-275

  Anagnostopoulos, George K ^a,b   Sakorafas, George H ^c   Kostopoulos, Panagiotis ^c   Margantinis, George ^c   Tsiakos, Stavros ^c   Terpos, Evaggelos ^c   Pavlakis, George ^c   Fortun, Paul ^b   Arvanitidis, Dimitrios ^c  

^a University of Nottingham ^*  (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c 251 GENERAL AIR FORCE HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EOSINOPHIL CHEMOTACTIC FACTOR; FLUOROURACIL; FOLINIC ACID; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 5; IRINOTECAN; VINCRISTINE;

ADULT; ALLERGIC DISEASE; BONE MARROW BIOPSY; CANCER PALLIATIVE THERAPY; CASE REPORT; COLON CANCER; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISSEMINATED CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; INTESTINE PERFORATION; LETTER; LIVER METASTASIS; LYMPH NODE METASTASIS; PARASITOSIS; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 14744304573     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20173     Document Type: Letter

References (24)

1. Rothenberg M: Eosinophilia. N Engl J Med 1998;338:1592-1600.
2. Walter R, Joller-Jemelka HI, Salomon F: Metastatic squamous cell carcinoma with marked blood eosinophilia and elevated serum interleukin-5 levels. Exp Hematol 2002;30:1-2.
3. Balian A, Bonte E, Naveau S: Intratumoral production of interleukin-5 leading to paraneoplastic peripheral eosinophilia in hepatocellular carcinoma. J Hepatol 2001;34:355-356.
4. Abali H, Engin H, Turker A, et al.: Hypereosinophilia and metastatic anaplastic carcinoma of uknown primary. Med Oncol 2001;18:285-288.
5. Rheinbach G: Uber des Verhalten des Leukozyten bei malignen Tumoren. Arch Klin Chir 1893;46:486-562.
6. Samoszuk M: Eosinophils and human cancer. Histol Histopathol 1997;12:807-812.
7. Bethwaite PB, Holloway LJ, Yeong ML, et al.: Effect of tumor associated tissue eosinophilia on survival in women with stage 1B carcinoma of the uterine cervix. J din Pathol 1993;46:1016-1020.
8. Goldsmith MM, Belchis DA, Cresson DH, et al.: The importance of eosinophils in head and neck cancer. Otolaryngol Head Neck Surg 1992;106:27-33.
9. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, et al.: Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer 2000;88:1544-1548.
10. Fauci AS, Harley JB, Roberts WC, et al.: NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982;97: 78-92.
11. Teoch SCB, Siow WY, Tan HT: Severe eosinophilia in disseminated gastric carcinoma. Singapore Med J 2000;41:232-234.
12. Aldebert D, Lamkhioued B, Desaint C, et al.: Eosinophils express a functional receptor for interferon alpha: Inhibitory role of interferon alpha on the release of mediators. Blood 1996;87: 2354-2360.
13. Schleimer RP, Bochner BS: The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994;94:1202-1213.
14. Wasserman S, Goetzl EJ, Ellman L, et al.: Tumor associated eosinophilotactic factor. N Engl J Med 1984;290:420-424.
15. Sanderson CJ: Interleukine-5, eosinophils and disease. Blood 1992;79:3101-3103.
16. Sonoda Y, Arai N, Ogawa M: Humoral regulation of eosinophilopoiesis in vitro: Analysis of the targets of interleukine-3, GM-CSF and interleukine-5. Leukemia 1989;1:14-18.
17. Wang JM, Rambaldi A, Blondi A, et al.: Recombinant human interleukine-5 is a selective eosinophil chemoattractant. Eur J Immunol 1989;19:701-705.
18. Simon HV, Yousefi S, Schranz C, et al.: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3952-3958.
19. Bosse M, Audete M, Ferland C, et al.: Gene expression of interleukine-2 in purified human peripheral eosinophils. Immunology 1996;87:149-154.
20. Fridlender ZG, Simon HU, Shalit M: Metastatic carcinoma presenting with concomitant eosinophilia and thromboembolism. Am J Med Sci 2003;326:98-101.
21. Watanabe M, Ono K, Ozeki Y, et al.: Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol 1998;28:559-562.
22. Nakada T, Sato H, Inoue F, et al.: The production of colony-stimulating factors by thyroid carcinoma is associated with marked neutrophilia and eosinophilia. Intern Med 1996;35:815-820.
23. Tajima K, Yamakawa M, Inaba Y, et al.: Cellular localization of interleukin-5 expression in rectal carcinoma with eosinophilia. Hum Pathol 1998;29:1024-1028.
24. Sawyers CL, Golde DW, Quan S, et al.: Production of granulocyte- macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis and eosinophilia. Cancer 1992;69:1342-1346.